Cardiovascular events after polychemotherapy of oncohematological diseases: modern ways to prevention and treatment
Heart dysfunction that occurred after using of cytostatic drugs and monoclonal antibodies may be a limit factor in treatment of oncohematological diseases. Side effects of chemotherapy include decline of quality of life, hypotension, hypertension, arrhythmias, conduction disturbances, pericarditis,...
Saved in:
| Main Author: | B. B. Samura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2013-06-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/13648/11901 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular events after polychemotherapy of multiple myeloma: modern ways to diagnostics
by: B. B. Samura, et al.
Published: (2020-03-01) -
Cardiovascular complications of polychemotherapy of oncohematological diseases: Modern approaches to diagnostics
by: B. B. Samura
Published: (2012-12-01) -
Multiple myeloma and cardiovascular risk (a literature review)
by: B. B. Samura, et al.
Published: (2020-11-01) -
Circulating VE-catherin and prognosis of cardiovascular events in remission of multiple myeloma
by: B. B. Samura
Published: (2016-06-01) -
Value of P-selectin in the prognosis of cardiovascular events in patients with multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-08-01)